Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States

Arthritis and Rheumatism

Volumn 41, Issue 5, 1998, Pages 778-799

  Lawrence, Reva C ^a   Helmick, Charles G ^b   Arnett, Frank C ^c   Deyo, Richard A ^d   Felson, David T ^e   Giannini, Edward H ^f   Heyse, Stephen P ^a   Hirsch, Rosemarie ^a   Hochberg, Marc C ^g   Hunder, Gene G ^h   Liang, Matthew H ⁱ   Pillemer, Stanley R ^a   Steen, Virginia D ^j   Wolfe, Frederick ^k  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^g UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^h MAYO CLINIC   (United States)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^j GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^k ARTHRITIS RESEARCH CENTER FOUNDATION   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTHRITIS; ARTICLE; CALCULATION; DISEASE ASSOCIATION; GIANT CELL ARTERITIS; HUMAN; MUSCULOSKELETAL DISEASE; OSTEOARTHRITIS; PREVALENCE; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SCLERODERMA; SELF REPORT; SPONDYLOARTHROPATHY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CONNECTIVE TISSUE DISEASES; FEMALE; HEALTH SURVEYS; HUMANS; INFANT; JOINT DISEASES; LOW BACK PAIN; MALE; MIDDLE AGED; PREVALENCE; TEMPORAL ARTERITIS; UNITED STATES;

EID: 0031968825     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V     Document Type: Article

References (149)

1. Lawrence RC, Hochberg MC, Kelsey JL, McDuffie FC, Medsger TA Jr, Felts WR, et al. Estimates of the prevalence of selected arthritis and musculoskeletal diseases in the United States. J Rheumatol 1989;16:427-41.
2. Felts W, Yelin E. The economic impact of the rheumatic diseases in the United States. J Rheumatol 1989;16:867-84.
3. McNeil JM. Americans with disabilities: 1991-1992. Current population reports. Washington (DC): US Bureau of the Census; 1993.
4. Ficke RC. Digest of data of persons with disabilities, 1992. Washington (DC): US Department of Education; 1992.
5. National Center for Health Statistics. Prevalence of selected impairments: United States 1977. Vital Health Stat 10 1981;134.
6. Kelsey J. Epidemiology of musculoskeletal disorders. New York: Oxford University Press; 1982.
7. Deyo RA, Tsui-Wu YJ. Descriptive epidemiology of low back pain and its related medical care in the United States. Spine 1987;12:264-8.
8. US Bureau of the Census. 1990 census of population and housing (special tabulation STP 82). Washington (DC): US Bureau of the Census; 1993.
9. Jabine T. Reporting chronic conditions in the NHIS: a review of tendencies from evaluation studies and methodological tests. Vital Health Stat 2 1995;105.
10. Edwards S. Evaluation of the National Health Interview Survey diagnostic reporting (report to the National Center for Health Statistics). Rockville (MD): Westat; 1992.
11. National Arthritis Data Workgroup. Arthritis prevalence and activity limitation - United States, 1990. MMWR Morb Mortal Wkly Rep 1994;43:433-8.
12. Helmick CG, Lawrence RC, Pollard RA, Lloyd E, Heyse SP, for the National Arthritis Data Workgroup. Arthritis and other rheumatic conditions: who is affected now, who will be affected later? Arthritis Care Res 1995;8:203-11.
13. Treitel R. Recovery of disabled beneficiaries: a 1975 followup study of 1972 allowances. Soc Secur Bull 1979;42:3-23.
14. Guccione AA, Felson DT, Anderson JJ, Anthony JM, Zhang Y, Wilson PWF, et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health 1994;84:351-8.
15. Kellgren JH, Lawrence JS. Atlas of standard radiographs. In: The epidemiology of chronic rheumatism. Vol. 2. Oxford: Blackwell Scientific Publications; 1963. p. 1-5.
16. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986;29:1039-49.
17. Altman R, Alarcón G, Appelrouth D, Bloch D, Borenstein D, Brandt K, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991;34:505-14.
18. Mikkelsen WM, Dodge HJ, Duff IF. Estimates of the prevalence of rheumatic diseases in the population of Tecumseh, Michigan, 1959-60. J Chronic Dis 1967;20:351-69.
19. Centers for Disease Control and Prevention. Estimated number of US population with physician-diagnosed osteoarthritis, 1990. Atlanta: Centers for Disease Control and Prevention; 1995.
20. Maurer K. Basic data on arthritis knee, hip and sacroiliac joints in adults ages 25-74 years, United States, 1971-1975. Vital Health Stat 11 1979;213.
21. Felson DT. Epidemiology of hip and knee osteoarthritis. Epidemiol Rev 1988;10:1-27.
22. Van Saase JLCM, van Romunde LKJ, Cats A, Vandenbroucke JP, Valkenburg HA. Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations. Ann Rheum Dis 1989;48:271-80.
23. Felson DT, Naimark A, Anderson J, Kazis L, Castelli W, Meenan RF. The prevalence of knee osteoarthritis in the elderly: the Framingham Osteoarthritis Study. Arthritis Rheum 1987;30: 914-8.
24. Lawrence JS, Bremner JM, Bier F. Osteo-arthrosis: prevalence in the population and relationship between symptoms and x-ray changes. Ann Rheum Dis 1966;25:1-24.
25. Helmick CG, Pollard RA, Jordan JM, Renner JB, Fryer JG, Hochberg MC. Evidence for underreading of radiographic osteoarthritis of the hips and knees in the first National Health and Nutrition Examination Survey [abstract]. Arthritis Rheum 1994;37 Suppl 9:S301.
26. Engle A. Osteoarthritis in adults by selected demographic characteristics, United States - 1960-1962. Vital Health Stat 11 1966; 20.
27. Wolfe F. Rheumatoid arthritis. In: Bellamy N, editor. Prognosis in the rheumatic diseases. Lancaster (UK): Kluwer Academic Publishers; 1991. p. 37-82.
28. Pincus T. Is mortality increased in patients with rheumatoid arthritis? J Musculoskeletal Med 1988;5:27-46.
29. Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA. 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958;9:175-6.
30. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
31. Lawrence JS. Rheumatism in populations. London: William Heinemann Medical; 1977.
32. O'Sullivan JB, Cathcart ES. The prevalence of rheumatoid arthritis: followup examination of the effect of criteria on rates in Sudbury, Massachusetts. Ann Intern Med 1972;76:572-7.
33. Mikkelsen WM, Dodge H. A four year follow-up of suspected rheumatoid arthritis: the Tecumseh, Michigan, Community Health Study. Arthritis Rheum 1969;12:87-91.
34. Engel A, Roberts J, Burch TA. Rheumatoid arthritis in adults: United States 1960-1962. Vital Health Stat 11 1966;17.
35. Cathcart ES, O'Sullivan JB. Rheumatoid arthritis in a New England town: a prevalence study in Sudbury, Massachusetts. N Engl J Med 1970;282:421-4.
36. Cunningham LS, Kelsey JL. Epidemiology of musculoskeletal impairments and associated disability. Am J Public Health 1984; 74:574-9.
37. Linos A, Worthington JW, O'Fallon WM, Kurland LT. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol 1980;111:87-98.
38. Jacobsson LTH, Hanson RL, Knowler WC, Pillemer S, Pettitt DJ, McCance DR, et al. Decreasing incidence and prevalence of rheumatoid arthritis in Pima Indians over a twenty-five-year period. Arthritis Rheum 1994;37:1158-65.
39. Dugowson CE, Koepsell TD, Voigt LF, Bley L, Nelson JL, Daling JR. Rheumatoid arthritis in women: incidence rates in Group Health Cooperative, Seattle, Washington, 1987-1989. Arthritis Rheum 1991;34:1502-7.
40. Brewer EJ Jr, Bass J, Baum J, Cassidy JT, Fink C, Jacobs J, et al. Current proposed revision of JRA criteria. Arthritis Rheum 1977;20 Suppl 2:195-9.
41. Cassidy JT, Levinson JE, Bass JC, Baum J, Brewer EJ Jr, Fink CW, et al. A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum 1986;29:274-81.
42. Singsen BH. Rheumatic diseases of childhood. Rheum Dis Clin North Am 1990;16:581-99.
43. Peterson LS, Mason T, Nelson AM, O'Fallon WM, Gabriel SE. Juvenile rheumatoid arthritis in Rochester, Minnesota 1960-1993: is the epidemiology changing? Arthritis Rheum 1996;39: 1385-90.
44. Hochberg MC, Linet MS, Sills EM. The prevalence and incidence of juvenile rheumatoid arthritis in an urban black population. Am J Public Health 1983;73:1202-6.
45. Hanson V, Kornreich HK, Bernstein B, King KK, Singsen BH. Three subtypes of juvenile rheumatoid arthritis: correlations of age at onset, sex, and serologic factors. Arthritis Rheum 1977;20 Suppl 2:184-6.
46. Arthritis Foundation. Arthritis information: arthritis in children. Atlanta: Arthritis Foundation; 1993.
47. Laxer RM. What's in a name: the nomenclature of juvenile arthritis. J Rheumatol 1993;20 Suppl 40:2-3.
48. Cassidy JT, Nelson AM. The frequency of juvenile arthritis. J Rheumatol 1988;15:535-6.
49. Gewanter HL, Baum J. The frequency of juvenile arthritis [letter]. J Rheumatol 1989;16:556.
50. Cassidy JT. What's in a name? Nomenclature of juvenile arthritis: a North American view. J Rheumatol 1993;20 Suppl 40:4-8.
51. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
52. Kellgren JH, Jeffrey MR, Ball J. The epidemiology of chronic rheumatism. Vol. I. Oxford: Blackwell Scientific; 1963.
53. Bennett PH, Burch TA. The epidemiological diagnosis of ankylosing spondylitis. In: Bennett PH, Wood PHN, editors. Population studies of the rheumatic diseases. Amsterdam: Excerpta Medica; 1968. p. 305-13.
54. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984;27: 361-8.
55. Van der Linden SM, Valkenburg HA, de Jongh BM, Cats A. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals: a comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 1984;27:241-9.
56. Khan MA, Braun WE, Kushner I, Grecek DE, Muir WA, Steinburg AG. HLA-B27 in ankylosing spondylitis: differences in frequency and relative risk in American blacks and Caucasians. J Rheumatol 1977;4 Suppl 3:39-43.
57. Baum J, Ziff M. The rarity of ankylosing spondylitis in the black race. Arthritis Rheum 1971;14:12-8.
58. Khan MA. Spondyloarthropathies in non-Caucasian populations of the world. In: Ziff M, Cohen SB, editors. Advances in inflammation research. Vol. 9. The Spondyloarthropathies. New York: Raven Press; 1985. p. 91-9.
59. Carter ET, McKenna CH, Brian DD, Kurland LT. Epidemiology of ankylosing spondylitis in Rochester, Minnesota, 1935-1973. Arthritis Rheum 1979;22:365-70.
60. Boyer GS, Templin DW, Cornoni-Huntley JC, Everett DF, Lawrence RC, Heyse SF, et al. Prevalence of Spondyloarthropathies in Alaskan Eskimos. J Rheumatol 1994;21:2292-7.
61. Gofton JP, Bennett PH, Smythe HA, Decker JL. Sacroilitis and ankylosing spondylitis in North American Indians. Ann Rheum Dis 1972;31:474-81.
62. Willkens RF, Arnett FC, Bitter T, Calin A, Fisher L, Ford DK, et al. Reiter's syndrome: evaluation of preliminary criteria for definite disease. Arthritis Rheum 1981;24:844-9.
63. Arnett FC. Incomplete Reiter's syndrome: clinical comparison with classical triad. Ann Rheum Dis 1979;38 Suppl:73-9.
64. Morse HG, Rate RG, Bonnell MD, Kuberski T. High frequency of HLA-B27 and Reiter's syndrome in Navajo Indians. J Rheumatol 1980;7:400-2.
65. Clark MR, Solinger AM, Hochberg MC. Human immunodeficiency virus infection is not associated with Reiter's syndrome: data from three large cohort studies. Rheum Dis Clin North Am 1992;18:267-76.
66. Hellgren L. Association between rheumatoid arthritis and psoriasis in total populations. Acta Rheumatol Scand 1969;15:316-26.
67. Farber EM, Grauer F, Zaruba F. Racial incidence of psoriasis. Cesk Dermatol 1965;40:289-97.
68. Gladman DD, Shuckett R, Russell ML, Thorne JC, Schacter RK. Psoriatic arthritis (PSA) - an analysis of 220 patients. QJM 1987;62:127-41.
69. Biondi Oriente C, Scarpa R, Pucino A, Oriente P. Psoriasis and psoriatic arthritis: dermatological and rheumatological cooperative clinical report. Acta Venereol 1989;146 Suppl:69-71.
70. Myren J, Bouchier IAD, Watkinson G, Softley A, Clamp SE, DeDombal FT. The OMGE multinational inflammatory bowel disease survey 1976-1986: a further report on 3,175 cases. Scand J Gastroenterol 1988;23 Suppl 144:11-9.
71. Schoenborn CA, Marano M. Current estimates from the National Health Interview Survey, United States, 1987. Vital Health Stat 10 1988;166.
72. Stonnington CM, Phillips SF, Melton LJ, Zinsmeister AR. Chronic ulcerative colitis: incidence and prevalence in a community. Gut 1987;28:402-9.
73. Gollop JH, Phillips SF, Melton LJ, Zinsmeister AR. Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982. Gut 1988;29:49-56.
74. Greenstein MB, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 1976;55:401-12.
75. Sloan WP, Bargen JA, Gage RP. Life histories of patients with chronic ulcerative colitis: a review of 2,000 cases. Gastroenterology 1950;16:25-38.
76. Van Patter WN, Bargen JA, Dockerty MB, Feldman WH, Mayo CW, Waugh JM. Regional enteritis. Gastroenterology 1954;26: 347-450.
77. Carette S, Graham D, Little H, Rubenstein J, Rosen P. The natural disease course of ankylosing spondylitis. Arthritis Rheum 1983;26:186-90.
78. Righy AS. Review of UK data on the rheumatic diseases. 5. Ankylosing spondylitis. Br J Rheumatol 1991;30:50-3.
79. Fox R, Calin A, Gerber RC, Gibson D. The chronicity of symptoms and disability in Reiter's syndrome. Ann Intern Med 1979;91:190-3.
80. Csonka GW. Long-term follow-up and prognosis of Reiter's syndrome. Ann Rheum Dis 1979;38 Suppl:24-8.
81. Roberts MET, Wright V, Hill AGS, Mehra AC. Psoriatic arthritis follow-up study. Ann Rheum Dis 1976;35:206-12.
82. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
83. Perez-Gutthann S, Petri M, Hochberg MC. Comparison of different methods of classifying patients with systemic lupus erythematosus. J Rheumatol 1991;18:1176-9.
84. Michel CJ Jr, McKenna CH, Elveback LR, Kaslow RA, Kurland LT. Epidemiology of systemic lupus erythematosus and other connective tissue disease in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 1985;60:105-13.
85. Lom-Orta H, Alarcon-Segovia D, Diaz-Jouanen E. Systemic lupus erythematosus differences between patients who do, and who do not fulfill classification criteria at the time of diagnosis. J Rheumatol 1980;7:831-7.
86. Ganczarczyk L, Urowitz M, Gladman DD. Latent lupus. J Rheumatol 1989;16:475-8.
87. Kurland LT, Hauser WA, Ferguson RH, Holley KE. Epidemiologic features of diffuse connective tissue disorders in Rochester, MN, 1951 through 1967, with special reference to systemic lupus erythematosus. Mayo Clin Proc 1969;44:649-63.
88. Siegel M, Lee SL. The epidemiology of systemic lupus erythematosus. Semin Arthritis Rheum 1973;3:1-54.
89. Fessel WJ. Systemic lupus erythematosus in the community; incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Arch Intern Med 1974;134:1027-35.
90. McCarty DJ, Manzi S, Medsger TA Jr, Ramsey-Goldman R, LaPorte RE, Kwoh CK. Incidence of systemic lupus erythematosus: race and gender differences. Arthritis Rheum 1995;38: 1260-70.
91. Serdula MK, Rhoads GG. Frequency of systemic lupus erythematosus in different ethnic groups in Hawaii. Arthritis Rheum 1979;22:328-33.
92. Catalane MA, Hoffmeier M. Frequency of systemic lupus erythematosus among the ethnic groups of Hawaii [abstract]. Arthritis Rheum 1989;32 Suppl 4:S30.
93. Merrell M, Shulman LE. Determination of prognosis in chronic disease illustrated by systemic lupus erythematosus. J Chronic Dis 1955;1:12-32.
94. Pistiner M, Wallace DJ, Nessin S, Metzger AL, Klinenberg JR. Lupus erythematosus in the 1980's: a survey of 570 patients. Semin Arthritis Rheum 1991;21:54-5.
95. Steen VD, Medsger TA Jr. Epidemiology and natural history of systemic sclerosis. Rheum Dis Clin North Am 1990;16:1-10.
96. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
97. Le Roy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
98. Steen VD. Systemic sclerosis. Rheum Dis Clin North Am 1990; 16:641-54.
99. Maricq HR, Weinrich MC, Keil JE, Smith EA, Harper FE, Nussbaum AI, et al. Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 1989;32:998-1006.
100. Steen VD, Oddis CV, Conte CG, Janoski J, Ziegler Casterline G, Medsger TA Jr. Incidence of systemic sclerosis in Allegheny County, Pennsylvania: a twenty-year study of hospital-diagnosed cases, 1963-1982. Arthritis Rheum 1997;40:441-5.
101. Silman A, Jannini S, Symmons D, Bacon P. An epidemiological study of scleroderma in the West Midlands. Br J Rheumatol 1988;27:286-90
102. Masi AT. Clinical-epidemiological perspective of systemic sclerosis (scleroderma). In: Jayson MIV, Black CM, editors. Systemic sclerosis: scleroderma. New York: John Wiley & Sons: 1988. p. 7.
103. Asboe-Hansen G. Epidemiology of progressive systemic sclerosis in Denmark. In: Black CM, Myers AR, editors. Systemic sclerosis (scleroderma). New York: Gower; 1985. p. 78.
104. Liang TJ, Gillespie BW, Toth MB, Mayes MD, Gallavan RH Jr, Burns CJ, et al. Racial differences in scleroderma among women in Michigan. Arthritis Rheum 1997;40:734-42.
105. Smith CA, Fidler WJ, Finals RS. The epidemiology of giant cell arteritis: report of a ten-year study in Shelby County, Tennessee. Arthritis Rheum 1983;26:1214-9.
106. Hunder GG, Lie JT, Goronzy JJ, Weyand CM. Pathogenesis of giant cell arteritis. Arthritis Rheum 1993;36:757-61.
107. Weyand CM, Hunder NNH, Hicok KC, Hunder GG, Goronzy JJ. HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis. Arthritis Rheum 1994;37:514-20.
108. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 1982;97:672-80.
109. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991. Arthritis Rheum 1995;38:369-73.
110. Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med 1978;88:162-7.
111. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.
112. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. The incidence of giant cell arteritis in Olmsted County: apparent fluctuations in a cyclic pattern. Ann Intern Med 1995;123:192-4.
113. Tate GA, Schumacher HR Jr. Gout. B. Clinical and laboratory features. In: Schumacher HR Jr, Klippel JH, Koopman WJ, editors. Primer on the Rheumatic Diseases. Atlanta: Arthritis Foundation; 1993. p. 213-6.
114. CIOMS Criteria, Rome. Appendix 1. Proposed diagnostic criteria for use in population studies. In: Kellgren JH, Jeffrey MR, Ball J, editors. The epidemiology of chronic rheumatism. Oxford: Blackwell Scientific; 1963. p. 324-6.
115. Bennett PH, Wood PHN, editors. Population studies of the rheumatic diseases. Amsterdam: Excerpta Medica; 1968.
116. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu T-F. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977;20:895-900.
117. O'Sullivan JB. Gout in a New England town: a prevalence study in Sudbury, Massachusetts. Ann Rheum Dis 1972;31:166-9.
118. Dawber TR, Kannel BW, Lyell LP. An approach to longitudinal studies in a community: the Framingham Study. Ann N Y Acad Sci 1963;107:539-56.
119. Hall AP, Barry PE, Dawber TR, McNamara PM. Epidemiology of gout and hyperuricemia: a long-term population study. Am J Med 1967;42:27-37.
120. Benson V, Marano MA. Current estimates from the National Health Interview Survey, United States, 1992. Vital Health Stat 10 1994;189.
121. Wolfe F, Hawley DJ. Fihromyalgia. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB, editors. Textbook of rheumatology (supplement). Philadelphia: WB Saunders; 1993. p. 2-16.
122. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 1990;33:160-72.
123. Hawley DJ, Wolfe F. Depression is not more common in rheumatoid arthritis: a 10 year longitudinal study of 6,608 rheumatic disease patients. J Rheumatol 1993;20:2025-31.
124. Muller W, Lautenschlager J. Die generalizierte Tendomyopathie (GTM) Teil I: Klinic, Velauf, und Differential diagnose. Z Rheumatol 1990;49:11-21.
125. Yunus MB, Masi AT, Calabro JJ, Miller KA, Feigenbaum SL. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981;11:151-71.
126. Raspe H, Baumgartner C, Wolfe F. The prevalence of fibromyalgia in a rural German community: how much difference do different criteria make? [abstract]. Arthritis Rheum 1993;36 Suppl 9:S48.
127. Wolfe F, Ross K, Anderson J, Russell L. Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol 1995;22:151-6.
128. Croft P, Schollum J, Silman A. Population study of tender point counts and pain as evidence of fibromyalgia. BMJ 1994;309: 696-9.
129. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
130. Buskila D, Press J, Gedalia A, Klein M, Neumann L, Boehm R, et al. Assessment of nonarticular tenderness and prevalence of fibromyalgia in children. J Rheumatol 1993;20:368-70.
131. Prescott E, Kjoller M, Jacobsen S, Bulow PM, Danneskiold-Samsoe B, Kamper-Jorgensen F. Fibromyalgia in the adult Danish population. I. Prevalence study. Scand J Rheumatol 1993;22:233-7.
132. Forseth KO, Gran JT. The prevalence of fibromyalgia among women aged 20-49 years in Arendal, Norway. Scand J Rheumatol 1992;21:74-8.
133. Makela M, Heliovaara M. Prevalence of primary fibromyalgia in the Finnish population. BMJ 1991;303:216-9.
134. Jacobsson L, Lindgarde F, Manthorpe R. The commonest rheumatic complaints of over six weeks' duration in a twelve-month period in a defined Swedish population: prevalences and relationships. Scand J Rheumatol 1989;18:353-60.
135. Lyddell C. The prevalence of fibromyalgia in a South African community [abstract]. Scand J Rheumatol 1992;94 Suppl:S143.
136. Walewski W, Szczepanski L. Epidemiological studies of fibromyalgia syndrome morbidity [abstract]. Scand J Rheumatol 1992;94 Suppl:S138.
137. Croft P, Rigby AS, Boswell R, Schollum J, Silman AJ. The prevalence of widespread pain in the general population. J Rheumatol 1993;20:710-3.
138. Wolfe F, Hawley DJ. Fibromyalgia in the adult Danish population [letter]. Scand J Rheumatol 1994;23:55.
139. Sternbach RA. Survey of pain in the United States: the Nuprin pain report. Clin J Pain 1986;2:49-53.
140. Quebec Task Force on Spinal Disorders. Scientific approach to the assessment and management of activity-related spinal disorders. Spine 1987;12 Suppl 7:512-5.
141. White AA, Gordon SL. Synopsis: workshop on idiopathic low back pain. Spine 1982;7:141-9.
142. Frymoyer JW, Pope MH, Clements JH, Wilder DG, MacPherson B, Ashikaga T. Risk factors in low-back pain: an epidemiological survey. J Bone Joint Surg Am 1983;65:213-8.
143. Olsen TL, Anderson RL, Dearwater SR, Kriska AM, Cauley JA, Aaron DJ, et al. The epidemiology of low back pain in an adolescent population. Am J Public Health 1992;82:606-8.
144. Nagi SZ, Riley LE, Newby LG. A social epidemiology of back pain in a general population. J Chronic Dis 1973;26:769-79.
145. Reisbord LS, Greenland S. Factors associated with self-reported back pain prevalence: a population-based study. J Chronic Dis 1985;38:691-702.
146. Kelsey JL, Golden AL, Mundt DJ. Low back pain/prolapsed lumbar intervertebral disc. Rheum Dis Clin North Am 1990;163: 699-715.
147. Kelsey JL, White AA. Epidemiology and impact of low back pain. Spine 1980;5:133-42.
148. Taylor H, Curran NM. The Nuprin report. New York: Louis Harris and Associates; 1985.
149. Savettieri G, Rocca WA, Slemi G. Prevalence of lumbosacral spondylitic radiculopathy (LSR): a door-to-door survey in two Sicilian municipalities [abstract]. Neurology 1992;42 Suppl 3:355.